idt corp (IDT.US) will release its financial report after market close on October 8th.
idt corp (IDT.US) will release its financial report after-hours on October 8th. How was the previous performance? In 2024/Q3, idt corp (IDT.US) had a revenue of 0.299643 billion USD, a net income of 6.342 million USD, and an EPS of 0.22 USD. In 2023/Q4, revenue was 0.303807 billion USD, net income was 8.758 million USD, and EPS was 0.31 USD. The above data is based on US_GAAP accounting principles. Futubull Reminder: 1. The accounting year division time of Hong Kong and U.S. listed companies is not strictly regulated, comp
IDT (NYSE:IDT) Could Become A Multi-Bagger
IDT Corp To Go Ex-Dividend On September 30th, 2024 With 0.05 USD Dividend Per Share
September 25th (Eastern Time) - $IDT Corp(IDT.US)$ is trading ex-dividend on September 30th, 2024.Shareholders of record on September 30th, 2024 will receive 0.05 USD dividend per share on October 7
IDT Corporation to Report Fourth Quarter and Fiscal Year 2024 Results
idt int'l (00167.HK) proposed restructuring arrangement hearing has been cancelled.
idt int'l (00167.HK) announced that the company has submitted a filing cessation notice to the High Court on September 9th of this year to suspend the original summons of the proposed restructuring arrangement plan, and the hearing scheduled to be held on September 13th has been canceled. The company stated that its shares will continue to be suspended from trading until a resumption guidance is reached.
Institutional Investors in IDT Corporation (NYSE:IDT) See US$61m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
NRSInsights' August 2024 Retail Same-Store Sales Report
Integrated DNA Technologies Bolsters Comprehensive Genomic Profiling Solutions With Launch of New Archer HRD Technology for Cancer Research
With 46% Ownership, IDT Corporation (NYSE:IDT) Has Piqued the Interest of Institutional Investors
Net2phone Introduces a Single-Pane-of-Glass View for Engaging Business Conversations Across Channels
idt int'l (00167.HK) is expected to report unaudited net profit of over 5 million yuan in the first half of the year.
idt int'l (00167.HK) supplements the profit forecast previously issued, and is expected to record unaudited net profit of over 5 million yuan in the first half of the year, compared to a net loss of about 6.8 million yuan in the same period last year. The main reason is the resumption of business operations in the first half of this year, while the operation was basically suspended in the first half of last year. The stock has been suspended since April 3 last year and will continue to be suspended until the resumption guidance is achieved.
idt int'l (00167.HK) resumes business operations of "Yingxi" and anticipates turning losses into profits.
idt int'l (00167.HK) announced profit for the period, is expected to record net profit for the six months ending June compared to a net loss of 6.8 million yuan in the same period last year. The reason is the recovery of business operations in the first half of this year. So far, the company has received more than 70 million yuan of confirmed orders, and it is expected to be completed and delivered in the third quarter of this year. The company's shares have been suspended from trading since April 3, 2023, and will continue to be suspended.
Idt int'l (00167.HK) narrowed its losses to 21.75 million yuan in 2022.
idt int'l (00167.HK) announced its annual results for the year ending in 2022, with revenue of 2.22 million yuan, down 87.1% from the previous year. Losses narrowed from 84.23 million yuan in the previous year to 21.75 million yuan, with a loss per share of 0.84 cents. No final dividends will be distributed. The company's shares will be suspended from trading starting from April 3, 2023, and will continue to be suspended.
Could The Market Be Wrong About IDT Corporation (NYSE:IDT) Given Its Attractive Financial Prospects?
Earnings Not Telling The Story For IDT Corporation (NYSE:IDT)
Integrated DNA Technologies Bolsters Synthetic Biology Portfolio With Launch of Rapid Genes and Significant Upgrades to Gene Synthesis Offerings
Idt Insider Sold Shares Worth $281,993, According to a Recent SEC Filing
Integrated DNA Technologies Announces New Licensing Agreement With SeQure Dx to Advance CRISPR-based Therapeutics
NRSInsights' June 2024 Retail Same-Store Sales Report
IDT Corp(IDT.US) Officer Sells US$18,105 in Common Stock
$IDT Corp(IDT.US)$ Officer SHEA NADINE sold 500 shares of common stock on Jul 2, 2024 at an average price of $36.21 for a total value of $18,105.Source: Announcement What is statement of changes in be